Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daria Di Molfetta"'
Autor:
Saad Saeed Alqahtani, Tomas Koltai, Muntaser E. Ibrahim, Adil H. H. Bashir, Sari T. S. Alhoufie, Samrein B. M. Ahmed, Daria Di Molfetta, Tiago M. A. Carvalho, Rosa Angela Cardone, Stephan Joel Reshkin, Abdelhameed Hifny, Mohamed E. Ahmed, Khalid Omer Alfarouk
Publikováno v:
Journal of Xenobiotics, Vol 12, Iss 3, Pp 158-180 (2022)
Replication is a fundamental aspect of cancer, and replication is about reproducing all the elements and structures that form a cell. Among them are DNA, RNA, enzymes, and coenzymes. All the DNA is doubled during each S (synthesis) cell cycle phase.
Externí odkaz:
https://doaj.org/article/433f794637a34d4c9808ce2ae37e2a56
Autor:
Federica Cappellesso, Marie-Pauline Orban, Niranjan Shirgaonkar, Emanuele Berardi, Jens Serneels, Marie-Aline Neveu, Daria Di Molfetta, Francesca Piccapane, Rosa Caroppo, Lucantonio Debellis, Tessa Ostyn, Nicolas Joudiou, Lionel Mignion, Elena Richiardone, Bénédicte F. Jordan, Bernard Gallez, Cyril Corbet, Tania Roskams, Ramanuj DasGupta, Sabine Tejpar, Mario Di Matteo, Daniela Taverna, Stephan J. Reshkin, Baki Topal, Federico Virga, Massimiliano Mazzone
Publikováno v:
Nature Cancer, Vol. 3, p. 1464-1483 (2022)
Solid tumors are generally characterized by an acidic tumor microenvironment (TME) that favors cancer progression, therapy resistance and immune evasion. By single-cell RNA-sequencing analysis in individuals with pancreatic ductal adenocarcinoma (PDA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2da78e9924fb0bc0407de8ed998830
https://lirias.kuleuven.be/handle/20.500.12942/712182
https://lirias.kuleuven.be/handle/20.500.12942/712182
Autor:
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Tomas Koltai, Khalid O. Alfarouk, Stephan J. Reshkin, Rosa A. Cardone
Publikováno v:
Cancers, Vol 13, Iss 6135, p 6135 (2021)
Cancers
Cancers
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis. The lack of early diagnosis and the absence of suitable biomarkers coupled with resistance to available therapeutic options has made PDAC one of the deadliest can